/PRNewswire/ Mestag Therapeutics ("Mestag"), an immunotherapy company harnessing new insights into fibroblast-immune interactions in cancer and inflammatory.
SV Health Investors Joins Prilenia Series B as the Company Prepares for ALS and HD Data Readouts in the Next 12 Months - read this article along with other careers information, tips and advice on BioSpace
The research team from Oxford University and the Imperial College London Diabetes Centre Abu Dhabi (ICLDC) think that these genetic traces reflect the movement of people in the Middle East after major cultural transitions, such as the invention of ag